“Once the exclusivity period and monopoly of patented medicines from innovative companies has passed, generic manufacturers are allowed to make cheaper copies of these drugs. As such, these companies ensure affordable drugs and broad access to sometimes life-saving medicines. However, increasingly society is confronted with shortages of these generic medications. On this topic and many other things, Henk Jan Out speaks with Anish Mehta, CEO of Synthon BV, an important manufacturer of complex generics.